J&J Slides as Device Margins Droop, Drug Sales Seen Falling [Yahoo! Finance]
Kenvue Inc. (KVUE)
Company Research
Source: Yahoo! Finance
Most Read from Bloomberg China Weighs Stock Market Rescue Package Backed by $278 Billion India Tops Hong Kong as World's Fourth-Largest Stock Market An Isolated Israel Doubles Down on War in Gaza — At All Costs Netflix Pays $5 Billion for ‘Raw' in Bet on Live Events Hong Kong Stocks at 36% Discount Show True Depth of China Gloom Medical technology margins declined due to costs of an acquisition, commodity inflation and an unfavorable product mix, executives said on an earnings call, and second-half pharma sales will slip as top-selling drug Stelara faces competition in Europe. The company affirmed its annual financial forecast, and said a US regulatory panel will look into a study of Carvykti, its Car-T treatment for multiple myeloma. The shares fell as much as 3.4% as of 11:23 a.m. in New York, their biggest intraday drop since August. J&J has narrowed its focus on its pharma and devices businesses after spinning off its less-profitable consumer unit as Kenvue Inc. W
Show less
Read more
Impact Snapshot
Event Time:
KVUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KVUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KVUE alerts
High impacting Kenvue Inc. news events
Weekly update
A roundup of the hottest topics
KVUE
News
- Kenvue Declares Quarterly Cash DividendBusiness Wire
- J&J Profit Beats Estimates as Pharma Sales Edge Out Street [BNN Bloomberg (Canada)]BNN Bloomberg
- Zimbabwe Recalls Tainted J&J's Cough Syrup Sold in Six African Nations [BNN Bloomberg (Canada)]BNN Bloomberg
- J&J's Tainted Cough Syrup Was Sold in Six African Countries [BNN Bloomberg (Canada)]BNN Bloomberg
- Kenvue Inc. (NYSE: KVUE) is now covered by analysts at Sanford C. Bernstein. They set an "underperform" rating and a $18.00 price target on the stock.MarketBeat
KVUE
Earnings
- 2/8/24 - Beat
KVUE
Sec Filings
- 4/10/24 - Form ARS
- 4/10/24 - Form DEFA14A
- 4/10/24 - Form DEF
- KVUE's page on the SEC website